NDC 49401-101-01
BENLYSTA 120 mg/1.5mL
belimumab · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
BENLYSTA is a injection, powder, lyophilized, for solution containing belimumab at a strength of 120 mg/1.5mL. Manufactured by GlaxoSmithKline LLC.
Key Facts
- Brand Name
- BENLYSTA
- Generic Name
- belimumab
- NDC Code (Package)
49401-101-01- NDC Code (Product)
49401-101- Manufacturer
- GlaxoSmithKline LLC
- Strength
- 120 mg/1.5mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA125370
- Drug Class
- B Lymphocyte Stimulator-specific Inhibitor [EPC]
- Marketing Start
- 03/10/2011
Recall History
No Recall HistoryView Full Drug Page
BENLYSTA — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.